Ingenerate VC is a Delaware co-investment syndicate backing Seed-Series A startups across LATAM, the US and Europe, with clean SPV execution and access to US follow-on capital.
A co-investment partner built for speed, alignment and cross-market access
ABOUT INGENERATE VC
Ingenerate VC is a Delaware-registered co-investment syndicate focused on Seed, Post-Seed and Series A opportunities across LATAM, the US and Europe. LATAM is an active exploration priority, with Brazil, Mexico, Colombia and Argentina at the center of our current coverage.
We co-invest alongside lead investors, align with their terms, and execute through clean deal-by-deal SPVs. For select LATAM companies, we support access to US follow-on capital through curated warm introductions.
For select high-conviction LATAM companies, we activate curated US and European investor relationships to support follow-on fundraising.
LATAM
Speed
We provide responsive co-invest capital with clear communication, reasonable timelines and efficient execution to help rounds close smoothly.
2025
Alignment
We do not lead rounds. We co-invest alongside the lead investor with pricing discipline and alignment on agreed terms.
Seed-A
Execution
We structure clean deal-by-deal SPVs with flexible jurisdiction, simple allocation, streamlined documentation and organized closing.
$8.0M LP
Investment focus
Stage:
Core sectors:
Geography: LATAM exploration priority - Brazil / Mexico / Colombia / Argentina; selective Chile / Peru / Uruguay - with active coverage of US and EU startups and continued connectivity to US/EU VC ecosystems.
Selective themes: Edtech / Silver Economy / HRtech / Renewable Energy / Agritech / Smart Cities / AI-enabled B2B software delivering measurable productivity and workflow efficiency gains and other exceptional opportunities.
Seed • Post-Seed • Series A
Fintech • Healthtech • Proptech
1
What we look for
Primary: companies with proven traction and/or clear PMF (assessed case-by-case) Selective earlier-stage: LATAM adaptations of proven US/EU models at MVP stage when timing and local execution are compelling
2
Target ticket size
Seed / Post-Seed: typically $250k–$400k Series A: typically $1.2M–$1.5M Final allocation depends on deal structure, syndicate appetite and standard approvals.
3
Deployment
Launched in 2025, active deployment with a confidential portfolio $8.0M LP capital committed for 2026 SPVs, allocated deal-by-deal (subject to standard approvals)
DEPLOYMENT & PORTFOLIO
Launched in 2025, Ingenerate VC is actively deploying capital through deal-by-deal SPVs into a curated group of companies and funds across AI, healthtech, deeptech, consumer wellness, creator economy and frontier technology.
Fitofan
Unified infrastructure and payments layer for sports federations, clubs and competitions worldwide.